Cargando…

Collaboration between Hepatologists and Primary Care Physicians in Treating Patients with Chronic Hepatitis C

Objective: The purpose of this study was to assess the treatment outcome in patients with chronic hepatitis C (CHC) using the current standard antiviral therapy when patient were treated in collaboration between hepatologists and primary care physicians (PCPs). Patients and Methods: One hundred and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tazawa, Junichi, Sakai, Yoshinori, Kusano, Fumihiko, Nagayama, Kazuyoshi, Fujiwara, Hideomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Association of Rural Medicine 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309350/ https://www.ncbi.nlm.nih.gov/pubmed/25648346 http://dx.doi.org/10.2185/jrm.6.54

Ejemplares similares

The Rate of Referral of Hepatitis Virus Carriers to Hepatologists and the Factors Contributing to Referral
por: Takata, Kazuhide, et al.
Publicado: (2017)

International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations
por: Cadranel, Jean-François David, et al.
Publicado: (2023)

Gastroenterologists, Hepatologists, COVID-19 and the Use of Acetaminophen
por: Rodríguez-Morales, Alfonso J., et al.
Publicado: (2020)

Palliative Care Always: Hepatology—Virtual Primary Palliative Care Training for Hepatologists
por: DeNofrio, Jan C., et al.
Publicado: (2021)

Factors influencing the participation of gastroenterologists and hepatologists in clinical research
por: Dev, Anouk T, et al.
Publicado: (2008)

Advancing health equity: The Association of Black Gastroenterologists and Hepatologists
por: White, Pascale M., et al.
Publicado: (2021)

What hepatologists need to know about COVID-19?
por: Yapali, Suna
Publicado: (2020)

Nonalcoholic Fatty Liver Disease in Diabetics: The Role of Hepatologist
por: Khandelwal, Reshu, et al.
Publicado: (2022)

Moving Toward Impact: An Introduction to Implementation Science for Gastroenterologists and Hepatologists
por: Rogal, Shari S., et al.
Publicado: (2020)

The liver in times of COVID-19: What hepatologists should know
por: Ridruejo, Ezequiel, et al.
Publicado: (2020)

Barriers to research productivity among gastroenterologists and hepatologists in Saudi Arabia
por: AlSardi, Mais, et al.
Publicado: (2020)

COVID-19-associated liver injury (COVALI): role of hepatologists
por: Sumida, Yoshio, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?
por: Khandelwal, Reshu, et al.
Publicado: (2021)

Reply to: “COVID-19-associated liver injury (COVALI): role of hepatologists”
por: Li, Dongxiao, et al.
Publicado: (2021)

The Perceived Ability of Gastroenterologists, Hepatologists and Surgeons Can Bias Medical Decision Making
por: Cucchetti, Alessandro, et al.
Publicado: (2020)

National Early Career Transplant Hepatologist Survey: Compensation, Burnout, and Job Satisfaction
por: Kriss, Michael, et al.
Publicado: (2021)

Care Pattern for Fontan-Associated Liver Disease by Academic Pediatric Hepatologists in Canada
por: Kehar, Mohit, et al.
Publicado: (2022)

Effects of esomeprazole on the healing process of post-endoscopic submucosal dissection gastric ulcers: a single arm, prospective trial
por: Ichida, Takashi, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Has the Time Come for Cardiologists to Be Hepatologists?
por: Ahmed, Mohamed H., et al.
Publicado: (2012)

Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know?
por: Sharma, Praveen, et al.
Publicado: (2021)

Sorafenib prescribed by gastroenterologists and hepatologists for hepatocellular carcinoma: A retrospective, multi-institutional cohort study
por: Kaplan, David E., et al.
Publicado: (2018)

Electronic Consultations to Hepatologists Reduce Wait Time for Visits, Improve Communication, and Result in Cost Savings
por: Bhavsar, Indira, et al.
Publicado: (2019)

Practice Habits, Knowledge, and Attitudes of Hepatologists to Alcohol Use Disorder Medication: Sobering Gaps and Opportunities
por: Cotter, Thomas G., et al.
Publicado: (2020)

The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States
por: Murayama, Anju, et al.
Publicado: (2022)

Characteristics of hepatocellular carcinoma in patients with hepatitis C virus who received direct‐acting antiviral therapy and achieved sustained virological response: The impact of a hepatologist on surveillance
por: Tada, Toshifumi, et al.
Publicado: (2022)

Comparative Hepatology: A journal for all hepatologists with immediate Open Access to quality peer-reviewed research
por: Rocha, Eduardo, et al.
Publicado: (2004)

Timing of Transjugular Intrahepatic Portosystemic Stent-shunt in Budd–Chiari Syndrome: A UK Hepatologist's Perspective
por: Khan, Faisal, et al.
Publicado: (2018)

A Call to Action: Novel Ways that Hepatologists Can Contribute to Patient Care During the COVID-19 Pandemic
por: Bloom, Patricia P.
Publicado: (2020)

Nonalcoholic steatohepatitis medical patient journey from the perspective of hepatologists, gastroenterologists and patients: a cross-sectional survey
por: Rinella, Mary, et al.
Publicado: (2022)

Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection
por: Ichida, Takashi, et al.
Publicado: (2018)

What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist’s Perspective
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2020)

Red Blood Cell Transfusions and Iron Therapy for Patients Presenting with Acute Upper Gastrointestinal Bleeding: A Survey of Canadian Gastroenterologists and Hepatologists
por: Fortinsky, Kyle J., et al.
Publicado: (2016)

Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?
por: Nones, Rodrigo Bremer, et al.
Publicado: (2017)

Review article: role of glucagon‐like peptide‐1 receptor agonists in non‐alcoholic steatohepatitis, obesity and diabetes—what hepatologists need to know
por: Barritt, A. Sidney, et al.
Publicado: (2022)

Chronic hepatitis C infection: how much are physicians aware of?
por: Kayar, Yusuf, et al.
Publicado: (2019)

A pharmacist‐physician collaborative care model in chronic kidney disease
por: Li, Hanlin, et al.
Publicado: (2021)

Primary care physicians' approach to diagnosis and treatment of hepatitis B and hepatitis C patients
por: Peksen, Yildiz, et al.
Publicado: (2004)

Community pharmacist and primary care physician collaboration: The missing connection in pharmaceutical care
por: Mazhar, Faizan, et al.
Publicado: (2016)

Hepatitis C virus knowledge improves hepatitis C virus screening practices among primary care physicians
por: Samuel, Sandeep T, et al.
Publicado: (2018)

Association of primary care physicians’ exercise habits and their age, specialty, and workplace
por: Morishita, Yoshiyuki, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9pc65mo2b037l4kv9bqml8ln6f